Related Experiment Video
Updated: Jan 1, 2026
08:27
Large-Scale Multi-Omics Genome-Wide Association Studies Mo-GWAS: Guidelines for Sample Preparation and Normalization
Published on: July 27, 2021
4.7K
Evaluating the consistency of large-scale pharmacogenomic studies
Raziur Rahman1, Saugato Rahman Dhruba1, Kevin Matlock1
1Department of Electrical and Computer Engineering, Texas Tech University, Lubbock, TX 79409, USA.
Briefings in Bioinformatics
|December 18, 2019
Summary
Pharmacogenomic databases like GDSC and CCLE are crucial for personalized cancer therapies but may contain inconsistencies. This study analyzes these discrepancies using copulas to ensure reliable data for cancer research.
Area of Science:
- Genomics
- Pharmacogenomics
- Bioinformatics
Background:
- Pharmacogenomic databases (e.g., GDSC, CCLE) offer genomic and drug sensitivity data for cancer cell lines.
- Inconsistencies between these databases may impact the validation of personalized cancer therapies.
Purpose of the Study:
- To review developments in assessing pharmacogenomic database correspondence.
- To identify factors influencing data consistency in modeling analyses.
- To explore database consistency using copula methods.
Main Methods:
- Literature review of pharmacogenomic database comparison studies.
- Analysis of potential discrepancies and influencing factors.
- Application of copula models to assess data consistency and nonlinear dependencies.
Main Results:
- Identified potential inconsistencies across major pharmacogenomic databases.
- Highlighted critical factors for consideration when integrating database information.
- Demonstrated the utility of copulas in quantifying database concordance.
Conclusions:
- Ensuring consistency across pharmacogenomic databases is vital for reliable personalized cancer therapy research.
- Careful consideration of data sources and analytical methods is necessary.
- Copula analysis provides a robust framework for evaluating database interrelationships.
Related Concept Videos
01:12Analysis of Population Pharmacokinetic Data
630
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
630
01:11Genome-wide Association Studies-GWAS
15.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
15.2K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
348
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
348
01:16Bioequivalence Data: Statistical Interpretation
163
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
163
01:26Pharmacokinetic Models: Comparison and Selection Criterion
283
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
283
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
116
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
116